Substance / Medication

Gemifloxacin

Overview

Active Ingredient
gemifloxacin
RxNorm CUI
138099

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

8 trials linked to this intervention

8
Total Trials
0
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Clinical effects of gemifloxacin on the delay of tuberculosis treatment.
Kim Seo Yun, Yim Jae-Joon, Park Jong Sun et al. · J Korean Med Sci · 2013
PMID: 23486643RCTFull text (PMC)
Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
Landersdorfer Cornelia B, Kirkpatrick Carl M J, Kinzig Martina et al. · Antimicrob Agents Chemother · 2009
PMID: 19564368RCTFull text (PMC)
Bioequivalence evaluation of 320 mg gemifloxacin tablets in healthy volunteers.
Al-Mohizea A M, Kadi A A, Al-Bekairi A M et al. · Int J Clin Pharmacol Ther · 2007
PMID: 18077928RCT
Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.
Islinger Florian, Bouw Rene, Stahl Mathias et al. · Antimicrob Agents Chemother · 2004
PMID: 15504848TrialFull text (PMC)
A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
Ball P, Mandell L, Patou G et al. · Int J Antimicrob Agents · 2004
PMID: 15120718Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Gemifloxacin (substance)
SNOMED CT
407086007
UMLS CUI
C0533545
RxNorm CUI
138099

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

8
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.